Alvesco and Pleurisy - a phase IV clinical study of FDA data

Summary:

Pleurisy is reported as a side effect among people who take Alvesco (ciclesonide), especially for people who are female, 40-49 old, also take Singulair, and have Middle insomnia.

The phase IV clinical study analyzes which people have Pleurisy when taking Alvesco. It is created by eHealthMe based on reports of 13,009 people who have side effects when taking Alvesco from the FDA, and is updated regularly.

What is Alvesco?

Alvesco has active ingredients of ciclesonide. It is often used in asthma. eHealthMe is studying from 13,134 Alvesco users. Check the latest studies of Alvesco.

What is Pleurisy?

Pleurisy (inflammation of the pleurae, which causes pain when breathing) is found to be associated with 808 drugs and 1,141 conditions by eHealthMe. Check the latest studies of Pleurisy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

13,009 people reported to have side effects when taking Alvesco.
Among them, 17 people (0.13%) have Pleurisy.

Among these 17 people:

What is the gender of people who have Pleurisy when taking Alvesco? *

female: 88.24 %
male: 11.76 %

What is the age of people who have Pleurisy when taking Alvesco? *

What are other drugs people take besides Alvesco? *

What are other side effects people have besides Pleurisy? *

Pneumonia: 15 people, 88.24%
Weight Decreased: 12 people, 70.59%
Ruptured Eardrum (tear in eardrum): 12 people, 70.59%
Malaise (a feeling of general discomfort or uneasiness): 12 people, 70.59%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 11 people, 64.71%
Wheezing (a high-pitched whistling sound made while you breath): 10 people, 58.82%
Oxygen Saturation Decreased: 10 people, 58.82%
Rashes (redness): 10 people, 58.82%
Dyspnea (difficult or laboured breathing): 10 people, 58.82%
Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body): 10 people, 58.82%

What are the existing conditions these people have? *

Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 9 people, 52.94%
Lung Infection: 7 people, 41.18%
Respiratory Disorder (respiratory disease): 2 people, 11.76%
Pneumonia: 2 people, 11.76%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Alvesco and have Pleurisy?

- Check whether Pleurisy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alvesco:

Alvesco (13,134 reports)

Pleurisy treatments and more:

Pleurisy (9,090 reports)

Browse all side effects of Alvesco:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pleurisy:

Pleurisy (808 drugs)

Browse all the conditions that are associated with Pleurisy:

Pleurisy (1,141 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide (the active ingredients of Alvesco) and Alvesco (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.